AllianceBernstein
PAVM icon

AllianceBernstein’s PAVmed PAVM Stock Holding History

AllianceBernstein’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-117
Closed -$70K – 3347
2022
Q1 		$70K Sell
117
-34
-23% -$25.3K ﹤0.01% 3147
2021
Q4 		$168K Buy
151
+61
+68% +$133K ﹤0.01% 3117
2021
Q3 		$345K Hold
90
– – ﹤0.01% 2912
2021
Q2 		$259K Buy
+90
New +$213K ﹤0.01% 3071
2020
Q3 		– Sell
-53
Closed -$51K – 3196
2020
Q2 		$51K Buy
+53
New +$53K ﹤0.01% 3160

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's PAVM Position: Q2 2022 in Review

AllianceBernstein sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 117 shares — an estimated $70K sold.

AllianceBernstein first reported a position in PAVM in Q2 2020 and held it in 5 quarters. The position peaked at $345K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • AllianceBernstein reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 117 PAVmed shares in Q2 2022, an estimated $70K.
  • AllianceBernstein first reported a position in PAVmed in Q2 2020 and held it in 5 quarters.
  • AllianceBernstein's PAVmed position peaked at $345K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.